- Know anybody who is tired of being ill?
- Who keeps getting misdiagnosed, overbilled by the medical system, dismissed for their “imaginary” symptoms?
Almost giving up on their health? - Want to say “Screw this!” and quit?
Tell them, “Not just yet!”
We are launching
an auction for crowdsourced health & wellness protocols and supply
powered by citizen-driven research and
non-clinical “alternative” holistic trials funded by the crowd
We dare you to believe
that together we will discover and co-create protocols that reverse currently “incurable” or chronic health conditions:
Lyme disease, Alzheimer’s, Cancer, Diabetes, HIV, Parkinson’s disease, Multiple sclerosis, Lupus, Polio etc.
Do you dare?
Stage of development:
MVP
pre-revenue
self-funded
Team:
The company has an experienced and passionate team of technical and business professionals.
3 co-founders, 6 developers (please see bios in our Investors deck).
INVESTOR DECK:
Available upon request to accredited investors. Please request it by filling in this form.
Please specify the project ID: 00026.
UPCOMING ONLINE EVENTS FOR INVESTORS:
Investor presentation and Q&A are scheduled for January 10, 11am PST. Contact us to register
_________________________________
OFFERING SUMMARY:
Class B Non-Voting Common Stock
Summary of Terms of Investment
*Company name: _____(to be disclosed to investors registered with SEARCHCrowdFUND)_____
The following summary (“Summary”) outlines the terms of a proposed investment in ___(company name)___, a Delaware LLC (the “Company”), by certain investors (the “Investors”). No legally binding obligations between the Company and any Investor will be created until definitive agreements are executed and delivered by the Company and the Investor, which agreements, and the Company’s governance documents, shall control in the event of any inconsistency or conflict with the terms of this Summary.
Target Investment:
This offering is for up to $1,000,000 in total investment.
Minimum Raise:
The minimum total investment for the closing of escrow and the purchase of stock is $200,000. After close of the Minimum Raise, the Company intends to close escrow as funds are raised up the Target Investment amount.
Target Closing Date:
The target closing date for this offering is on or before March 30, 2020, unless extended in the Company’s sole discretion.
Investors:
Accredited investors pursuant to a 506(c) offering.
Instrument:
The investment instrument is Series B Non-Voting Common Stock (the “Shares”).
Stock Price:
$1 per Share.
Number of Shares:
Up to 500,000 Shares are being offered as part of this offering (out of a total of 1,000,000 authorized shares of Class B Non-Voting Common Stock).
Capitalization Summary:
Immediately preceding this offering, the Company had, on a fully diluted basis, 300,000 Class A common stock issued or committed (including unexercised warrants and options representing 3,000,000 shares), plus 500,000 shares of class B non-voting stock. If this offering is fully subscribed, the Company would have a total of 510,000 shares of Class A Voting Common Stock and Class B Non-Voting Common Stock (collectively, “Common Stock”) issued or committed on a fully diluted basis on closing of this offering.
It is the intent of the Company to issue an additional 3,000,000 shares of Class B Non-Voting Common Stock, at a stock price likely to be higher the current offering price of $1.25 per share (but do not guaranty that any future equity raise will be at a greater stock price) through a Title IV offering as soon as possible following the completion of this 506(c) offering. The Company may sell or otherwise issue additional Class B Non-Voting Common Stock or other stock in the future.
Minimum Investment:
$20,000 per Investor (20,000 Shares).
Dividends:
Payable when and if declared by the Board of Directors. Any dividends will be paid on Common Stock in proportion to the aggregate number of Common Stock shares issued and outstanding.
Voting Rights:
The Shares are non-voting except as otherwise required by applicable law.
Liquidation Preference:
In the event of a liquidation, dissolution or winding up of the Company, the holders of the Shares shall be entitled to receive any distributions available to the holders of Common Stock on a pro rata basis to the holders of the shares of Common Stock.
Restriction on Sale:
The Shares are subject to Market Stand-Off provisions and other restrictions on sale.
Reports:
The Company will, for so long as is required under applicable law, file an annual report on Form C-AR within 120 days after the Company’s fiscal year end and post the report on the Company’s website.
